Conditions: Renal Cell Cancer Metastatic Kidney Cancer Metastatic
Keywords: Metastatic Renal Cell Metastatic Kidney Cancer
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 7
Healthy volunteers: no

Brief summary:
The purpose of this study is to determine whether Interleukin-2 at the dose and schedule used in this study will help increase tumor shrinkage.

Detailed description:
In this phase II study, the IL-2 schedule (daily IL-2 for 5 days (per week) every 3 weeks) will be tested in a cohort of kidney cancer patients to attempt to determine the response rate, median duration of response, and median survival. The dose intensity of this schedule would allow a patient treated on this regimen to achieve the target threshold (\> 1440 million IU/m2/year).

Arms:
arm 1: Interleukin-2

Interventions: intervention 1: Interleukin-2
Intervention descriptions: intervention 1: Interleukin-2

Protocol document: